New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
16:02 EDTSGNTSagent Pharmaceuticals launches Flumazenil Injection
Sagent Pharmaceuticals announced the launch of Flumazenil Injection, USP, a benzodiazepine antagonist, in two latex-free vial presentations. According to IMS for the 12 months ending September 2012, the US market for Flumazenil Injection, USP approximated $5.6M. As with all products in Sagent's portfolio, Flumazenil features the company's PreventIV Measures(SM) packaging and labeling, designed to help reduce medication errors.
News For SGNT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
07:05 EDTSGNTNeedham to hold a conference
Subscribe for More Information
April 13, 2015
06:03 EDTSGNTSagent Pharmaceuticals launches Vancomycin Hydrochloride for Injection
Sagent Pharmaceuticals announced the launch of Vancomycin Hydrochloride for Injection, USP, an anti-infective, in a 10 gram preservative-free pharmacy bulk package presentation. The Vancomycin 10 gram presentation is an addition to Sagent's Vancomycin 5 gram pharmacy bulk package offering. According to IMS, for the 12 months ending February, the US market for Vancomycin approximated $196M of which over fifty percent of the sales was pharmacy bulk package bottles.
April 8, 2015
10:01 EDTSGNTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
April 7, 2015
16:11 EDTSGNTSagent Pharmaceuticals initiated with a Buy at Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use